iStock/Getty Images
Biorhythms And Birth Control: FDA Stirs Debate By Approving ‘Natural’ App
Critics worry about the message federal officials are sending by approving a new birth control option, which uses a mobile phone app for women to track their body temperature and menstrual cycle to avoid pregnancy. But the more choices the better, some reproductive health experts say.
Rehabilitation Plus Rehab? Jails Dispense Drugs To Treat Inmates’ Addictions
Rather than go cold turkey, inmates increasingly have the option to take medication to help beat addiction to opioids and other substances. But some warn these substitute drugs serve as another crutch — and a costly one at that.
The Man Who Sold America On Vitamin D — And Profited In The Process
The doctor most responsible for turning the sunshine supplement into a billion-dollar juggernaut has received hundreds of thousands of dollars from the vitamin D industry, according to government records and interviews.
Babies Dependent On Opioids Need Touch, Not Tech
One doctor in Kansas works to make sure every hospital in the state can provide the soft start, ideally with their mothers, that babies with neonatal abstinence syndrome need.
Purdue Pharma's Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
Hospitals Battle For Control Over Fast-Growing Heart-Valve Procedure
Energy-Hog Hospitals: When They Start Thinking Green, They See Green
Podcast: KHN’s ‘What The Health?’ See You In Court!
States Leverage Federal Funds To Help Insurers Lower Premiums
Financial Ties That Bind: Studies Often Fall Short On Conflict-Of-Interest Disclosures
Listen: Why Young Doctors Appear To Be Embracing Single-Payer
‘No One Is Ever Really Ready': Aid-In-Dying Patient Chooses His Last Day
Feds Urge States To Encourage Cheaper Plans Off The Exchanges
Dan DeLong for KHN
Aid-In-Dying Patient Chooses His Last Day
With its expansion to Hawaii this year, medical aid-in-dying is now approved in eight U.S. jurisdictions. Even when legal, the controversial practice of choosing to die after a terminal diagnosis is difficult, said one Seattle man who shared his final deliberations.
Stay informed by signing up for the KHN Morning Briefing and other emails:
